(Q37763262)

22 August 2017

1 reference

title

Vascular PAR-1: activity and antagonism (English)

1 reference

22 August 2017

Ninian N Lang

1

1 reference

22 August 2017

Ingibjörg J Guðmundsdóttir

series ordinal

2

1 reference

22 August 2017

David E Newby

series ordinal

3

1 reference

22 August 2017

language of work or name

1 reference

27 May 2010

1 reference

Cardiovascular Therapeutics

22 August 2017

published in

1 reference

22 August 2017

volume

29

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

349-361

1 reference

Platelet activation and atherothrombosis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Role of platelets in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Triggers, targets and treatments for thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Variability in responsiveness to oral antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Oral blockade of the platelet glycoprotein IIb/IIIa receptor: fact or fancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Clinical overview of promising nonthienopyridine antiplatelet agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Basic and translational research on proteinase-activated receptors: antagonism of the proteinase-activated receptor 1 for thrombin, a novel approach to antiplatelet therapy for atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

21 January 2018

New antithrombotic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Intrinsic pathway of coagulation and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Intertwining of thrombosis and inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Protease-activated receptors in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Protease-activated receptors in hemostasis, thrombosis and vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Protease-activated receptors: contribution to physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Role of Protease-activated Receptors in the Vascular System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Protease-activated receptors in the musculoskeletal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Thrombin signalling and protease-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Protease activated receptors in cardiovascular function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Platelet adhesion and signaling induced by the octapeptide primary binding sequence (KOGEOGPK) from type III collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Role of thrombin signalling in platelets in haemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Protection against thrombosis in mice lacking PAR3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Thrombin receptor expression in normal and atherosclerotic human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Thrombin and Phenotypic Modulation of the Endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Altered vascular injury responses in mice deficient in protease-activated receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Protease-activated receptors in cardiovascular health and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Stimulated tissue plasminogen activator release as a marker of endothelial function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5922.2010.00140.X

10.1111/J.1755-5922.2010.00140.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference